NUWE Profile
Nuwellis, Inc., headquartered in Eden Prairie, Minnesota, is a medical device company specializing in ultrafiltration therapy for managing fluid overload in patients. Established in 1999 and formerly known as CHF Solutions, Inc., the company rebranded to Nuwellis, Inc. in April 2021 to better reflect its focus on innovation in fluid management solutions. Nuwellis is dedicated to advancing its product portfolio to improve patient outcomes and address critical needs in the treatment of fluid overload.
The company’s flagship product, the Aquadex FlexFlow system, is designed to provide effective fluid removal for patients who have not responded to traditional diuretic treatments. This system comprises a console, a disposable blood set, and a catheter, offering a comprehensive solution for ultrafiltration therapy. The Aquadex FlexFlow system is noted for its precision in managing fluid balance, which is crucial for patients with conditions such as heart failure, renal disease, and chronic fluid overload.
Nuwellis also offers the Aquadex SmartFlow system, an advanced version of its ultrafiltration technology. The SmartFlow system is equipped with enhanced monitoring and control features to optimize therapy and improve patient safety. Both systems are designed to support clinical environments by providing reliable, efficient fluid management solutions and contributing to better patient care.
Nuwellis markets its products primarily through a direct salesforce in the United States and independent specialty distributors in various international markets, including Austria, Brazil, Germany, Greece, and Hong Kong. The company’s global distribution network underscores its commitment to expanding access to its innovative solutions and addressing fluid management needs worldwide. Through its ongoing efforts in product development and global outreach, Nuwellis aims to lead advancements in ultrafiltration therapy and enhance patient quality of life.
|
